BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 6697964)

  • 1. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol-stimulated increases in uterine eosinophils and nuclear type II estrogen-binding sites are prevented by pertussis toxin.
    Lyttle CR; Teuscher C; Medlock KL; Sheehan DM
    Endocrinology; 1989 Nov; 125(5):2773-9. PubMed ID: 2792007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth.
    Clark JH; Williams M; Upchurch S; Eriksson H; Helton E; Markaverich BM
    J Steroid Biochem; 1982 Feb; 16(2):323-8. PubMed ID: 7078167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
    Ferguson ER; Katzenellenbogen BS
    Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of individual uterine cell types from immature rats treated with estradiol.
    McCormack SA; Glasser SR
    Endocrinology; 1980 May; 106(5):1634-49. PubMed ID: 6153974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
    Gardner RM; Kirkland JL; Stancel GM
    Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete early changes in cellular subpopulations of rat uterine and anterior pituitary estrogen receptors in response to acute exposure to exogenous estradiol.
    Copland JA; Smanik EJ; Muldoon TG
    J Steroid Biochem; 1987 Jun; 26(6):723-31. PubMed ID: 3613573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B; Palumbo LA
    Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal treatment with sex steroids: relationship between the uterotropic response and the estrogen "receptor" in prepubertal rats.
    Gellert RJ; Lewis J; Pétra PH
    Endocrinology; 1977 Feb; 100(2):520-8. PubMed ID: 12934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen action in the mouse uterus: adrenal modulation of receptor levels.
    Quarmby VE; Fox-Davies C; Swaisgood MH; Korach KS
    Endocrinology; 1982 Apr; 110(4):1208-16. PubMed ID: 7060522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen regulation of prolactin gene transcription in vivo: paradoxical effects of 17 beta-estradiol dose.
    Shull JD; Gorski J
    Endocrinology; 1989 Jan; 124(1):279-85. PubMed ID: 2909367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen action in the mouse uterus: the influence of the neuroendocrine-adrenal axis.
    Quarmby VE; Fox-Davies C; Korach KS
    Endocrinology; 1984 Jan; 114(1):108-15. PubMed ID: 6690267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal nuclear estrogen receptor binding: synchrony in athymic mouse uterus and human breast tumor xenografts.
    Beckman WC; Hudspeth DA; Golding T; Hubbert L; Akkerman J; Korach KS
    Endocrinology; 1989 Jun; 124(6):2651-8. PubMed ID: 2721439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.